Skip to content
zameds

Enrofloxacin (Enroxil Flavour, Karifloxx)

Enrofloxacin

Biotech Laboratories (Pty) Ltd

S4

Registration

Applicant
Biotech Laboratories (Pty) Ltd
Registrations
4
Schedule source
Consolidated Schedules 06 July 2026

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Enroxil flavour15 MG

Each tablet contains: Enrofloxacin 15 mg

15 mg21/0221/17.1.6/02RegisteredS4None
Enroxil flavour 50 MG

Each Tablet contains: Enrofloxacin 50 mg

50 mg21/0321/17.1.6/03RegisteredS4None
Enroxil flavour 150 MG

Each Tablet contains: Enrofloxacin 150 mg

150 mg21/0421/17.1.6/04RegisteredS4None
Karifloxx 100 mg/ml

Each 1,0 ml Solution contains: Enrofloxacin 100,0 mg

100 mgOral solution21/2721/17.1.6/27Approved 25 March 2025RegisteredS4PI

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Enrofloxacin

  • S4: Enrofloxacin

    Consolidated Schedules 06 July 2026, line 6191

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C19H22FN3O3359.40 g/mol

1-Cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxoquinoline-3-carboxylic acid

Drag to rotate. Structure from PubChem CID 71188.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

This medication's schedule (S4) has been verified from official SAHPRA documents with 90% confidence.

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles